Big Health Care Stocks to Watch in the New Year

01:01am, Thursday, 29'th Dec 2022
Here are three health care stocks to watch as the New Year begins. Two have a moderate Buy rating while one is a Hold, for now.

Final Trades: Visa, AT&T & more

02:13pm, Tuesday, 27'th Dec 2022
The "Halftime Report" traders give their top picks to watch for the second half.
Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
It's been an otherwise poor year for this biotech on the stock market.
Here are two I'm looking to add as we head into what could be another frustrating year for stocks.
Kevin Simpson, Capital Wealth Planning, joins 'Closing Bell: Overtime' to offer his five star playbook in energy, consumer staples and health care.
The biotech sector has been outperforming the major U.S. indices for the past few months. Can the strength continue?
Merck & Co. Inc. MRK, -0.34% said Thursday that it entered into an agreement with Sichuan Kelun Pharmaceutical Co. Ltd. 002422, -1.85% to develop seven new cancer therapies.
RAHWAY, N.J.--( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive officer, is scheduled to pa
New Year 2023 will see a continued tightening of monetary policy as the Federal Reserve attempts to rein in sky-high inflation. Following the 50 basis point rate hike in Dec., there are expectations t
Merck (MRK) and Seagen's (SGEN) sBLAs seek approval of Padcev plus Keytruda for locally advanced or metastatic urothelial cancer in patients who are not eligible for cisplatin-containing chemotherapy.
Many investors brush off unusual options activity, but others like to “follow the flow.

Merck: Why The Company Is Still Undervalued

11:24am, Tuesday, 20'th Dec 2022
Thanks to its leading positions in various therapeutic areas, Merck's revenue was $14,959 million in Q3 2022, an increase of 13.7% compared to the previous year. In September 2022, Japan MHLW approved
Want to know how to invest in 2023? Red-hot fund manager Dale Harvey says individual investors should fasten their seat belts.
Moderna and Merck are up on the news regarding their melanoma cancer vaccine.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE